Comfrey: Topical Use for Sprains and Bruises

You rolled your ankle. It is swollen, it hurts to put weight on it, and someone has handed you a tube of comfrey cream. The reasonable question is whether that tube does anything a bag of frozen peas would not.

The answer, unusually for a herbal remedy, is yes — and the evidence is specific enough to be worth reading in detail. Standardized comfrey preparations have been tested in four randomised controlled trials of acute ankle sprain, together enrolling roughly 670 patients. Two of those trials compared comfrey directly with diclofenac gel, the standard pharmacy anti-inflammatory rub, and comfrey was not beaten. That is a stronger evidence base than most over-the-counter topical products carry.

⚠ Before any of that matters, the rule that governs this whole herb: comfrey is for the outside of the body only. It contains pyrrolizidine alkaloids, which cause irreversible and sometimes fatal liver injury when swallowed — documented in human deaths, including from comfrey tea. Oral comfrey is banned or restricted in the United States, the United Kingdom, Germany, Canada and Australia. Those alkaloids also cross broken skin, so even a topical product goes on intact skin only, for a short course (typically no more than 10 days), never in pregnancy or breastfeeding, and not on children.

Table of Contents

1. What a Sprain Actually Is
2. The Two Products That Were Tested
3. The Placebo-Controlled Ankle Trial
4. Comfrey Versus Diclofenac Gel
5. The Dose-Response Trial
6. Bruises and Blunt Injury
7. Why It Would Work at All
8. How to Use It Properly
9. What It Will Not Do: Bones
10. The Honest Limits of This Evidence
11. Cautions and Contraindications
12. Key Research Papers
13. Connections

What a Sprain Actually Is

A sprain is a stretched or partly torn ligament — the tough fibrous band that holds two bones together at a joint. Roll your foot inward and you typically injure the anterior talofibular ligament on the outside of the ankle, which is why the swelling and the tender spot sit just in front of and below the bony knob of your outer ankle.

What hurts is not really the torn fibres themselves. Within minutes, damaged cells release inflammatory mediators; small blood vessels leak; fluid and inflammatory cells flood the tissue. The joint swells, the pressure rises, and nerve endings that were quiet become exquisitely sensitive. That is why a sprain often hurts more two hours later than at the moment of injury.

So a topical treatment has two plausible jobs: reduce the inflammatory response, and reduce the pain signal. It does not need to repair the ligament — the body does that over weeks regardless. It needs to make the first week bearable and get the joint moving sooner, because early controlled movement is what actually prevents a stiff, chronically unstable ankle. The trials below measured exactly that: pain, swelling, and range of motion.

The Two Products That Were Tested

Every one of these trials used a defined commercial preparation, and the two differ enough that you should know which is which.

• Comfrey root ointment (trial name: Kytta-Salbe f, made by Merck in Germany). A fluid extract of Symphytum officinale root in an ointment base. The root is the alkaloid-rich part of the plant, so the extract is processed to reduce pyrrolizidine alkaloid content.
• Comfrey herb cream (trial name: Traumaplant, made by Harras Pharma Curarina in Germany). A cream containing 10 % of a 2.5:1 aqueous-ethanolic pressed concentrate of freshly harvested aerial parts of Symphytum × uplandicum Nyman — equivalent to about 25 g of fresh herb per 100 g of cream. The manufacturer uses a selected cultivar and specifies the alkaloid content as below the limit of detection.

This distinction is not pedantry. A jar of home-made salve simmered from comfrey root you dug out of the garden is a different product from either: unknown extract strength, unknown alkaloid load, and made from the part of the plant with the most alkaloid in it. The trial results do not transfer to it.

The Placebo-Controlled Ankle Trial

The cleanest single piece of evidence is a multicentre, randomised, double-blind, placebo-controlled trial published in Phytomedicine in 2004 by Koll and colleagues.

• Who: 142 patients with unilateral acute ankle sprain, mean age 31.8 years, 78.9 % male — a sports-injury population.
• What: comfrey root ointment or an identical-looking placebo ointment, applied four times a day for 8 days.
• How measured: pain was quantified with a tonometer — a calibrated instrument that presses on the injured area with a known force, so the reading is not just a patient’s impression. Swelling was measured with the figure-of-eight tape method around the ankle. Mobility used the neutral-zero method.
• Result: comfrey beat placebo on pain (p<0.0001, the primary endpoint) and on ankle oedema (p=0.0001), with significant differences in mobility and global efficacy as well. No adverse drug reactions were reported in the active group.

Two things make this trial better than the average herbal study. The primary outcome was an instrument reading rather than a questionnaire, and the design was double-blind against a matched placebo ointment — which matters, because rubbing anything on a sore ankle four times a day produces a real placebo effect through massage, attention and expectation.

Comfrey Versus Diclofenac Gel

The trial people actually want to know about compared comfrey with the thing they would otherwise buy.

Predel and colleagues (Phytomedicine, 2005) ran an observer-blind, randomised, multicentre trial in 164 outpatients with acute unilateral ankle sprain, mean age 29, split evenly: 82 received a 6 cm strip of comfrey root ointment, 82 received diclofenac gel containing 1.16 g of diclofenac diethylamine salt, both four times daily for 7 ± 1 days. The primary outcome was the area under the curve of tonometer-measured pressure pain over the treatment week.

The trial was designed as a non-inferiority study — the question was whether comfrey was not worse than diclofenac, not whether it was better. It passed: the 95 % confidence interval for the difference lay entirely above the non-inferiority margin, and the authors noted the direction of the secondary outcomes favoured comfrey.

A follow-up publication (D’Anchise and colleagues, Arzneimittelforschung, 2007) re-analysed the same 164-patient dataset for superiority rather than non-inferiority, and reported a mean difference of +61.1 h·N/cm² in comfrey’s favour (95 % CI 19.08 to 103.09), concluding comfrey was superior. This is important to read correctly: it is one trial reported twice, not two independent trials. Re-analysing an existing dataset with a different hypothesis is a weaker form of evidence than pre-specifying superiority from the start, and anyone counting up “how many studies show comfrey beats diclofenac” should count one, not two.

Even read conservatively, though, the finding is meaningful. Diclofenac gel is a real drug with real efficacy in soft-tissue injury. A plant extract matching it in a head-to-head trial with instrument-based endpoints is a genuine result.

The Dose-Response Trial

The fourth ankle trial (Kucera and colleagues, Wiener Medizinische Wochenschrift, 2004) took a different and rather clever approach. Instead of comparing comfrey with an inert placebo, it compared a 10 % comfrey herb cream against a 1 % version of the same cream — 203 patients with acute ankle distortion, 104 on the strong version and 99 on the weak one.

The strong cream produced significantly better reductions in pain on movement, pain at rest, and functional impairment at days 3–4 and day 7 (p<0.001), and better reduction of swelling at days 3–4 (p<0.01). Physicians rated efficacy good to excellent in 85.6 % of the high-dose group versus 65.7 % of the low-dose group.

The strength of this design is that it demonstrates a dose-response relationship — more comfrey, more effect — which is one of the classic arguments that a drug is doing something real rather than reflecting expectation. Its weakness is that the “control” still contained comfrey, so the trial cannot tell you how much of the benefit in either arm was placebo. Notice, too, that the 65.7 % rating in the 1 % arm is itself high — sprains improve on their own, and quickly.

Bruises and Blunt Injury

Here honesty requires a step down in confidence. Comfrey is traditionally the bruise herb — the old name bruisewort is as common as knitbone — and comfrey creams are widely marketed for bruising. But there is no randomised controlled trial of comfrey for bruises as a standalone condition. What exists is:

• Ankle sprain trials, which are blunt soft-tissue injuries and do involve bruising and swelling, where comfrey measurably reduced oedema.
• A myalgia trial in 215 patients showing reduced muscle pain, which is closely related to the deep soreness of a contusion.
• An abrasion-healing trial in 278 patients, covered in the wound-healing article.

Applying comfrey to a bruise is therefore a reasonable extrapolation from adjacent evidence, not a demonstrated indication. If you want a topical herb with bruise-specific trial data, arnica has been studied more directly for that purpose, and a Cochrane review found arnica gel performed similarly to ibuprofen gel in hand osteoarthritis. Comfrey’s trial evidence is in sprains, back pain and knee osteoarthritis.

Why It Would Work at All

For years the obvious criticism of these trials was that nobody could say how a comfrey ointment could reduce swelling. That gap has now largely closed.

A 2019 study in Frontiers in Pharmacology exposed primary human endothelial cells — the cells lining blood vessels, which orchestrate the leaky, sticky, inflamed state around an injury — to interleukin-1, then treated them with a hydroalcoholic comfrey root extract. The extract dose-dependently suppressed the pro-inflammatory programme: E-selectin, VCAM-1, ICAM-1 and COX-2 expression all fell. Those are precisely the adhesion molecules that recruit white cells into injured tissue, plus the enzyme that non-steroidal anti-inflammatories inhibit.

The extract achieved this by blocking NF-κB, the master transcriptional switch for inflammation, at two separate steps: it dampened activation of IKK1/2 and the resulting degradation of IκBα, and it separately interfered with the p65 subunit’s shuttling into the nucleus and its transcriptional activity. Notably, the mucilage-depleted fraction was more active than the whole extract — so the slippery polysaccharides that make comfrey feel soothing are not the anti-inflammatory part.

Alongside that, comfrey root contains rosmarinic acid and other phenolic acids with antioxidant activity, and allantoin, which stimulates cell proliferation. That is a coherent package for a soft-tissue injury: less inflammatory signalling, less oxidative stress, more tissue turnover. It is cell-culture work rather than human pharmacokinetics, and it does not prove the same thing happens under a layer of skin — but it removes the “there is no plausible mechanism” objection.

How to Use It Properly

Match what you do to what the trials did.

Reading a label. A product worth buying tells you the species (Symphytum officinale or S. × uplandicum), the plant part (root or herb), the extract ratio or the percentage of concentrate, and something explicit about pyrrolizidine alkaloid content — “PA-free,” “alkaloid content below the limit of detection,” or a stated maximum in micrograms. A label that says only “comfrey extract” in a proprietary blend tells you nothing you can act on. Expect to pay roughly what a branded diclofenac gel costs; cost is rarely the deciding factor here, disclosure is.

Availability. In Germany and much of the EU, comfrey root preparations for external use are registered traditional herbal medicines with defined labelling. In the United States they are sold as cosmetics, which means no equivalent regulatory scrutiny of the extract — and the specific products used in these trials are often not the ones on the shelf. Buy from a manufacturer that publishes its alkaloid testing.

What It Will Not Do: Bones

The folk name is knitbone, and the tradition — going back to Dioscorides — held that a comfrey poultice bound over a fracture would help the bone fuse. The Greek genus name Symphytum itself means roughly “to grow together.”

There is no human trial showing that comfrey speeds fracture healing. Not a small one, not a poor one — none. What comfrey has been shown to do is reduce pain, swelling and stiffness in the soft tissue around an injury, which would make a splinted limb more comfortable without touching the bone. Given that a poultice sits on the skin and a fracture line sits centimetres deeper under muscle and periosteum, the folk claim was always mechanically improbable.

This matters practically. A suspected fracture needs imaging and immobilisation, and treating it with a herbal ointment while it heals crookedly is a genuinely bad outcome. If you cannot bear weight, if there is deformity, if there is bony point tenderness over the malleolus or the base of the fifth metatarsal, or if the pain is out of proportion — get an X-ray. Comfrey is for the sprain you have already had confirmed as a sprain.

The Honest Limits of This Evidence

1. Sponsorship. The ankle trials were run or authored by staff at the companies that make the products — Merck Selbstmedikation for the root ointment, the Traumaplant investigators for the herb cream. Industry-sponsored trials systematically report larger effects. Treat every number here as an upper estimate.
2. Independent replication is thin. No independent research group has repeated these trials with its own funding. An independent scoping review of comfrey’s external uses reached exactly this conclusion — promising, methodologically limited, and in need of research the manufacturers did not pay for.
3. One dataset, two papers. The 2005 non-inferiority paper and the 2007 superiority paper describe the same 164 patients.
4. Short horizons. Nothing here runs longer than about three weeks. That is appropriate — comfrey should not be used longer — but it means there is no evidence at all about repeated or long-term use, which is precisely where cumulative alkaloid exposure would matter.
5. Product-specific. These results belong to two named German preparations. A generic “comfrey cream” of unknown strength is untested.
6. Sprains get better anyway. Most ankle sprains improve substantially within one to two weeks with no treatment. Comfrey shortens the miserable part; it does not change the destination.

Cautions and Contraindications

⚠ Never take comfrey internally, in any form. No tea, no capsules, no tincture, no eating the leaves. Pyrrolizidine alkaloids cause hepatic veno-occlusive disease, which is often irreversible and has killed people. See Never Take It Internally.

• Intact skin only. Percutaneous absorption of comfrey’s alkaloids has been measured directly in animals. Intact skin is a real barrier — oral dosing produced 20 to 50 times more urinary alkaloid excretion than dermal dosing in that study — but broken skin removes it. No open wounds, cuts, grazes, ulcers, weeping eczema or mucous membranes.
• Time-limit the course. About 10 days of self-treatment is the standard European limit for comfrey root preparations, and German dosing rules additionally cap external use at roughly four to six weeks total per year.
• Not in pregnancy or breastfeeding. Pyrrolizidine alkaloids cross the placenta and enter breast milk, and the developing liver is the target organ. This applies to topical use too.
• Not on children. Follow the product’s age restriction, which for comfrey root preparations is generally 12 or 18 years. Children have far more skin surface per kilogram of body weight than adults, so the same smear delivers a proportionally larger dose.
• Avoid with liver disease — hepatitis, cirrhosis, fatty liver disease — or when taking medication that already stresses the liver.
• Do not cover with an occlusive dressing unless the label says to. Occlusion increases absorption of anything applied under it.
• Boraginaceae allergy. Contact dermatitis is uncommon but reported; the small American knee trial saw two participants per active group develop temporary rash and itching. Stop if the skin reacts.
• Drug interactions. There is no meaningful interaction data for topical comfrey, largely because systemic absorption of the active constituents is low. The theoretical concern is additive liver burden, so be cautious alongside methotrexate, azathioprine, isoniazid, high-dose paracetamol or any drug with known hepatotoxicity — and be sceptical of any product combining topical comfrey with an oral herbal blend.
• Wash your hands after applying, and keep it away from eyes and mouth.

Key Research Papers

Every identifier below was verified live against NCBI E-utilities — title, first author, journal and year all had to match before a PMID link was written.

1. Koll R, Buhr M, Dieter R, et al. Efficacy and tolerance of a comfrey root extract (Extr. Rad. Symphyti) in the treatment of ankle distorsions: results of a multicenter, randomized, placebo-controlled, double-blind study. Phytomedicine. 2004;11(6):470–477. — 142 patients; comfrey root ointment four times daily for 8 days beat placebo for pain and oedema, with no adverse drug reactions reported.
2. Predel HG, Giannetti B, Koll R, Bulitta M, Staiger C. Efficacy of a comfrey root extract ointment in comparison to a diclofenac gel in the treatment of ankle distortions. Phytomedicine. 2005;12(10):707–714. — 164 patients, 82 per arm; comfrey confirmed non-inferior to diclofenac diethylamine gel over 7 days.
3. D’Anchise R, Bulitta M, Giannetti B. Comfrey extract ointment in comparison to diclofenac gel in the treatment of acute unilateral ankle sprains (distortions). Arzneimittelforschung. 2007;57(11):712–716. — A superiority re-analysis of the same 164-patient dataset. Not an independent second trial.
4. Kucera M, Barna M, Horáček O, Kováriková J, Kucera A. Efficacy and safety of topically applied Symphytum herb extract cream in the treatment of ankle distortion: results of a randomized controlled clinical double blind study. Wiener Medizinische Wochenschrift. 2004;154(21–22):498–507. — 203 patients; 10 % cream beat a 1 % version of itself, demonstrating dose-response but not placebo control.
5. Kucera M, Barna M, Horàcek O, Kàlal J, Kucera A, Hladìkova M. Topical Symphytum herb concentrate cream against myalgia: a randomized controlled double-blind clinical study. Advances in Therapy. 2005;22(6):681–692. — 215 patients with back muscle pain; number needed to treat 3.2.
6. Kucera M, Kálal J, Polesná Z. Effects of Symphytum ointment on muscular symptoms and functional locomotor disturbances. Advances in Therapy. 2000;17(4):204–210. — The earlier, smaller observational precursor to the myalgia work.
7. Seigner J, Junker-Samek M, Plaza A, et al. A Symphytum officinale root extract exerts anti-inflammatory properties by affecting two distinct steps of NF-κB signaling. Frontiers in Pharmacology. 2019;10:289. — Cell culture. The mechanism study; the mucilage-depleted fraction was the more active one.
8. Frost R, MacPherson H, O’Meara S. A critical scoping review of external uses of comfrey (Symphytum spp.). Complementary Therapies in Medicine. 2013;21(6):724–745. — The independent appraisal of the whole external-use literature.
9. Frost R, O’Meara S, MacPherson H. The external use of comfrey: a practitioner survey. Complementary Therapies in Clinical Practice. 2014;20(4):347–355. — What practitioners actually do with comfrey, including on broken skin, which the authors flag as a safety concern.
10. Staiger C. Comfrey: a clinical overview. Phytotherapy Research. 2012;26(10):1441–1448. — Comprehensive, but written by an author affiliated with the manufacturer of the trial ointment.
11. Brauchli J, Lüthy J, Zweifel U, Schlatter C. Pyrrolizidine alkaloids from Symphytum officinale L. and their percutaneous absorption in rats. Experientia. 1982;38(9):1085–1087. — Animal study. Skin absorption is measurable; oral dosing gave 20 to 50 times higher urinary excretion.
12. Cameron M, Chrubasik S. Topical herbal therapies for treating osteoarthritis. Cochrane Database of Systematic Reviews. 2013;(5):CD010538. — Not a sprain review, but the only fully independent systematic appraisal of any topical comfrey trial.

Live PubMed Searches

1. Comfrey and ankle sprain
2. Symphytum officinale ointment
3. Comfrey versus diclofenac
4. Topical NSAIDs for soft-tissue injury
5. Ankle sprain treatment trials
6. Rosmarinic acid anti-inflammatory activity
7. Arnica for bruising
8. Comfrey percutaneous absorption

Connections

• All Herbs
• Comfrey Benefits — hub
• Comfrey — main topic page
• Osteoarthritis and Back Pain
• Wound Healing and Allantoin
• ⚠ Never Take It Internally
• Orthopedics — sprains, strains and joint injury
• Butterbur — the other alkaloid-bearing herb
• Calendula — for skin that is actually broken
• Marshmallow Root — mucilage without the alkaloids

Back to Table of Contents

×